UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
SMC develops protocol to transplant kidney, bone marrow without immunosuppressant
Samsung Medical Center (SMC) researchers have developed a protocol that suc...
by Lee Han-soo
|
2019-11-11 15:39
라인
'Impact factor for Korean Journal of Radiology outpaces US counterpart'
Korea Society of Radiology (KSR) said it is showing remarkable prowess in t...
by Lee Han-soo
|
2019-11-11 14:34
라인
Medpacto releases trial results at US conference
Medpacto, a subsidiary of Theregen ETEX, said Monday that it has presented ...
by Lee Han-soo
|
2019-11-11 13:27
라인
Yuhan, Cyclica to co-develop new drugs
Yuhan Corp. said that it would develop a new drug with Cyclica, a Canadian ...
by Lee Han-soo
|
2019-11-07 18:01
라인
KIST-Dongguk researchers use composite images to track stem cell growth
Stem cells have long received significant attention recently because of the...
by Lee Han-soo
|
2019-11-07 16:27
라인
AMC confirms efficacy of radiofrequency ablation therapy on thyroid cancer
A research team at Asan Medical Center has confirmed, through an extended f...
by Lee Han-soo
|
2019-11-07 15:20
라인
Celltrion marks robust Q3 sales
Celltrion said that it has recorded sales of 289.1 billion won ($249 millio...
by Lee Han-soo
|
2019-11-07 14:03
라인
Samsung Bioepis, Biogen to commercialize next-generation biosimilar candidates
Samsung Bioepis said the company would strengthen its partnership with Biog...
by Lee Han-soo
|
2019-11-07 11:16
라인
'AI accurately diagnoses abnormalities from chest X-rays'
Researchers at Seoul National University Hospital have confirmed that artif...
by Lee Han-soo
|
2019-11-07 08:25
라인
‘One-third of heart attack survivors overlook risk of recurrence’
Amgen Korea has released findings from a survey on Korean heart attack surv...
by Lee Han-soo
|
2019-11-06 16:34
라인
Crystal Genomics, Daehwa win patent for patch-form arthritis drug
Crystal Genomics and Daehwa Pharmaceutical said they have registered a pate...
by Lee Han-soo
|
2019-11-06 15:57
라인
Dong-A ST's treatment of nail athlete's foot dominates local market
Dong-A ST is strengthening its position in the toenail athlete's foot t...
by Lee Han-soo
|
2019-11-06 14:09
라인
SNUBH 1st local hospital to get certification from global accreditor
Seoul National University Bundang Hospital (SNUBH) said that it has become ...
by Lee Han-soo
|
2019-11-06 14:08
라인
Neofect wins patent for wearable robot glove
Neofect said that it has acquired a patent for Neomano, a wearable robotic ...
by Lee Han-soo
|
2019-11-05 17:51
라인
‘Extracorporeal shock wave therapy effective in treating chronic prostatitis’
Researchers at St. Mary’s Seoul Hospital have confirmed the efficacy of ext...
by Lee Han-soo
|
2019-11-05 17:16
라인
Cell Return acquires Speclipse
Cell Return, a local beauty healthcare firm, said it is diversifying its bu...
by Lee Han-soo
|
2019-11-05 16:49
라인
Daewoong to sell Merck's cardiovascular disease treatment
Merck Biopharma Korea said that Daewoong would market Concor, its cardiovas...
by Lee Han-soo
|
2019-11-05 15:05
라인
Samsung BioLogics to make Ichnos Sciences’ atopic dermatitis treatment
Samsung Biologics said that it has signed a contract with Ichnos Sciences t...
by Lee Han-soo
|
2019-11-05 12:47
라인
[Interview with global pharmas] 'Pfizer Korea combines Pfizer's outstanding innovation with Koreans’ talents'
Pfizer Korea has recently celebrated its 50th anniversary. Over the past ha...
by Lee Han-soo
|
2019-11-05 12:46
라인
Hanmi’s oral anticancer treatment becomes orphan drug in Europe
Hanmi Pharmaceutical said that Athenex, its U.S. partner, has won orphan dr...
by Lee Han-soo
|
2019-11-01 17:50
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top